According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Neurovascular Devices for Hemorrhagic Stroke Market

The global market for Neurovascular Devices for Hemorrhagic Stroke was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Neurovascular Devices for Hemorrhagic Stroke, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurovascular Devices for Hemorrhagic Stroke.

The Neurovascular Devices for Hemorrhagic Stroke market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neurovascular Devices for Hemorrhagic Stroke market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Neurovascular Devices for Hemorrhagic Stroke manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Neurovascular Devices for Hemorrhagic Stroke Market Report

Report Metric	Details
Report Name	Neurovascular Devices for Hemorrhagic Stroke Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type	Support Devices Neurothrombectomy Devices
Segment by Application	Hospitals Clinics
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Stryker Corporation, Medtronic, Johnson & Johnson, Terumo, Abbott Vascular, Acandis, Cerenovus, Ceres Endovascular, Imperative Care, Penumbra, MicroPort Scientific, NICO Corporation, Phenox, Rapid Medical, Shape Memory Medical, Wallaby Medical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neurovascular Devices for Hemorrhagic Stroke manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neurovascular Devices for Hemorrhagic Stroke in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Neurovascular Devices for Hemorrhagic Stroke Market report?

Ans: The main players in the Neurovascular Devices for Hemorrhagic Stroke Market are Stryker Corporation, Medtronic, Johnson & Johnson, Terumo, Abbott Vascular, Acandis, Cerenovus, Ceres Endovascular, Imperative Care, Penumbra, MicroPort Scientific, NICO Corporation, Phenox, Rapid Medical, Shape Memory Medical, Wallaby Medical

What are the Application segmentation covered in the Neurovascular Devices for Hemorrhagic Stroke Market report?

Ans: The Applications covered in the Neurovascular Devices for Hemorrhagic Stroke Market report are Hospitals, Clinics

What are the Type segmentation covered in the Neurovascular Devices for Hemorrhagic Stroke Market report?

Ans: The Types covered in the Neurovascular Devices for Hemorrhagic Stroke Market report are Support Devices, Neurothrombectomy Devices

1 Neurovascular Devices for Hemorrhagic Stroke Market Overview

1.1 Product Definition

1.2 Neurovascular Devices for Hemorrhagic Stroke by Type

1.2.1 Global Neurovascular Devices for Hemorrhagic Stroke Market Value Comparison by Type (2024 VS 2031)

1.2.2 Support Devices

1.2.3 Neurothrombectomy Devices

1.3 Neurovascular Devices for Hemorrhagic Stroke by Application

1.3.1 Global Neurovascular Devices for Hemorrhagic Stroke Market Value by Application (2024 VS 2031)

1.3.2 Hospitals

1.3.3 Clinics

1.4 Global Neurovascular Devices for Hemorrhagic Stroke Market Size Estimates and Forecasts

1.4.1 Global Neurovascular Devices for Hemorrhagic Stroke Revenue 2020-2031

1.4.2 Global Neurovascular Devices for Hemorrhagic Stroke Sales 2020-2031

1.4.3 Global Neurovascular Devices for Hemorrhagic Stroke Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Neurovascular Devices for Hemorrhagic Stroke Market Competition by Manufacturers

2.1 Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Manufacturers (2020-2025)

2.2 Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Neurovascular Devices for Hemorrhagic Stroke Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Neurovascular Devices for Hemorrhagic Stroke, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Neurovascular Devices for Hemorrhagic Stroke, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Neurovascular Devices for Hemorrhagic Stroke, Product Type & Application

2.7 Global Key Manufacturers of Neurovascular Devices for Hemorrhagic Stroke, Date of Enter into This Industry

2.8 Global Neurovascular Devices for Hemorrhagic Stroke Market Competitive Situation and Trends

2.8.1 Global Neurovascular Devices for Hemorrhagic Stroke Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Neurovascular Devices for Hemorrhagic Stroke Players Market Share by Revenue

2.8.3 Global Neurovascular Devices for Hemorrhagic Stroke Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Neurovascular Devices for Hemorrhagic Stroke Market Scenario by Region

3.1 Global Neurovascular Devices for Hemorrhagic Stroke Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Neurovascular Devices for Hemorrhagic Stroke Sales by Region: 2020-2031

3.2.1 Global Neurovascular Devices for Hemorrhagic Stroke Sales by Region: 2020-2025

3.2.2 Global Neurovascular Devices for Hemorrhagic Stroke Sales by Region: 2026-2031

3.3 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Region: 2020-2031

3.3.1 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Region: 2020-2025

3.3.2 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Region: 2026-2031

3.4 North America Neurovascular Devices for Hemorrhagic Stroke Market Facts & Figures by Country

3.4.1 North America Neurovascular Devices for Hemorrhagic Stroke Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2020-2031)

3.4.3 North America Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Neurovascular Devices for Hemorrhagic Stroke Market Facts & Figures by Country

3.5.1 Europe Neurovascular Devices for Hemorrhagic Stroke Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2020-2031)

3.5.3 Europe Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Market Facts & Figures by Region

3.6.1 Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Sales by Region (2020-2031)

3.6.3 Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Neurovascular Devices for Hemorrhagic Stroke Market Facts & Figures by Country

3.7.1 Latin America Neurovascular Devices for Hemorrhagic Stroke Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2020-2031)

3.7.3 Latin America Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Neurovascular Devices for Hemorrhagic Stroke Market Facts & Figures by Country

3.8.1 Middle East and Africa Neurovascular Devices for Hemorrhagic Stroke Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2020-2031)

3.8.3 Middle East and Africa Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Neurovascular Devices for Hemorrhagic Stroke Sales by Type (2020-2031)

4.1.1 Global Neurovascular Devices for Hemorrhagic Stroke Sales by Type (2020-2025)

4.1.2 Global Neurovascular Devices for Hemorrhagic Stroke Sales by Type (2026-2031)

4.1.3 Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Type (2020-2031)

4.2 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Type (2020-2031)

4.2.1 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Type (2020-2025)

4.2.2 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Type (2026-2031)

4.2.3 Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Type (2020-2031)

4.3 Global Neurovascular Devices for Hemorrhagic Stroke Price by Type (2020-2031)

5 Segment by Application

5.1 Global Neurovascular Devices for Hemorrhagic Stroke Sales by Application (2020-2031)

5.1.1 Global Neurovascular Devices for Hemorrhagic Stroke Sales by Application (2020-2025)

5.1.2 Global Neurovascular Devices for Hemorrhagic Stroke Sales by Application (2026-2031)

5.1.3 Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Application (2020-2031)

5.2 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Application (2020-2031)

5.2.1 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Application (2020-2025)

5.2.2 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Application (2026-2031)

5.2.3 Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Application (2020-2031)

5.3 Global Neurovascular Devices for Hemorrhagic Stroke Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Stryker Corporation

6.1.1 Stryker Corporation Company Information

6.1.2 Stryker Corporation Description and Business Overview

6.1.3 Stryker Corporation Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Stryker Corporation Neurovascular Devices for Hemorrhagic Stroke Product Portfolio

6.1.5 Stryker Corporation Recent Developments/Updates

6.2 Medtronic

6.2.1 Medtronic Company Information

6.2.2 Medtronic Description and Business Overview

6.2.3 Medtronic Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Medtronic Neurovascular Devices for Hemorrhagic Stroke Product Portfolio

6.2.5 Medtronic Recent Developments/Updates

6.3 Johnson & Johnson

6.3.1 Johnson & Johnson Company Information

6.3.2 Johnson & Johnson Description and Business Overview

6.3.3 Johnson & Johnson Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Johnson & Johnson Neurovascular Devices for Hemorrhagic Stroke Product Portfolio

6.3.5 Johnson & Johnson Recent Developments/Updates

6.4 Terumo

6.4.1 Terumo Company Information

6.4.2 Terumo Description and Business Overview

6.4.3 Terumo Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Terumo Neurovascular Devices for Hemorrhagic Stroke Product Portfolio

6.4.5 Terumo Recent Developments/Updates

6.5 Abbott Vascular

6.5.1 Abbott Vascular Company Information

6.5.2 Abbott Vascular Description and Business Overview

6.5.3 Abbott Vascular Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Abbott Vascular Neurovascular Devices for Hemorrhagic Stroke Product Portfolio

6.5.5 Abbott Vascular Recent Developments/Updates

6.6 Acandis

6.6.1 Acandis Company Information

6.6.2 Acandis Description and Business Overview

6.6.3 Acandis Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Acandis Neurovascular Devices for Hemorrhagic Stroke Product Portfolio

6.6.5 Acandis Recent Developments/Updates

6.7 Cerenovus

6.7.1 Cerenovus Company Information

6.7.2 Cerenovus Description and Business Overview

6.7.3 Cerenovus Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Cerenovus Neurovascular Devices for Hemorrhagic Stroke Product Portfolio

6.7.5 Cerenovus Recent Developments/Updates

6.8 Ceres Endovascular

6.8.1 Ceres Endovascular Company Information

6.8.2 Ceres Endovascular Description and Business Overview

6.8.3 Ceres Endovascular Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Ceres Endovascular Neurovascular Devices for Hemorrhagic Stroke Product Portfolio

6.8.5 Ceres Endovascular Recent Developments/Updates

6.9 Imperative Care

6.9.1 Imperative Care Company Information

6.9.2 Imperative Care Description and Business Overview

6.9.3 Imperative Care Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Imperative Care Neurovascular Devices for Hemorrhagic Stroke Product Portfolio

6.9.5 Imperative Care Recent Developments/Updates

6.10 Penumbra

6.10.1 Penumbra Company Information

6.10.2 Penumbra Description and Business Overview

6.10.3 Penumbra Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Penumbra Neurovascular Devices for Hemorrhagic Stroke Product Portfolio

6.10.5 Penumbra Recent Developments/Updates

6.11 MicroPort Scientific

6.11.1 MicroPort Scientific Company Information

6.11.2 MicroPort Scientific Description and Business Overview

6.11.3 MicroPort Scientific Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2020-2025)

6.11.4 MicroPort Scientific Neurovascular Devices for Hemorrhagic Stroke Product Portfolio

6.11.5 MicroPort Scientific Recent Developments/Updates

6.12 NICO Corporation

6.12.1 NICO Corporation Company Information

6.12.2 NICO Corporation Description and Business Overview

6.12.3 NICO Corporation Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2020-2025)

6.12.4 NICO Corporation Neurovascular Devices for Hemorrhagic Stroke Product Portfolio

6.12.5 NICO Corporation Recent Developments/Updates

6.13 Phenox

6.13.1 Phenox Company Information

6.13.2 Phenox Description and Business Overview

6.13.3 Phenox Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Phenox Neurovascular Devices for Hemorrhagic Stroke Product Portfolio

6.13.5 Phenox Recent Developments/Updates

6.14 Rapid Medical

6.14.1 Rapid Medical Company Information

6.14.2 Rapid Medical Description and Business Overview

6.14.3 Rapid Medical Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Rapid Medical Neurovascular Devices for Hemorrhagic Stroke Product Portfolio

6.14.5 Rapid Medical Recent Developments/Updates

6.15 Shape Memory Medical

6.15.1 Shape Memory Medical Company Information

6.15.2 Shape Memory Medical Description and Business Overview

6.15.3 Shape Memory Medical Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Shape Memory Medical Neurovascular Devices for Hemorrhagic Stroke Product Portfolio

6.15.5 Shape Memory Medical Recent Developments/Updates

6.16 Wallaby Medical

6.16.1 Wallaby Medical Company Information

6.16.2 Wallaby Medical Description and Business Overview

6.16.3 Wallaby Medical Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Wallaby Medical Neurovascular Devices for Hemorrhagic Stroke Product Portfolio

6.16.5 Wallaby Medical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Neurovascular Devices for Hemorrhagic Stroke Industry Chain Analysis

7.2 Neurovascular Devices for Hemorrhagic Stroke Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Neurovascular Devices for Hemorrhagic Stroke Production Mode & Process Analysis

7.4 Neurovascular Devices for Hemorrhagic Stroke Sales and Marketing

7.4.1 Neurovascular Devices for Hemorrhagic Stroke Sales Channels

7.4.2 Neurovascular Devices for Hemorrhagic Stroke Distributors

7.5 Neurovascular Devices for Hemorrhagic Stroke Customer Analysis

8 Neurovascular Devices for Hemorrhagic Stroke Market Dynamics

8.1 Neurovascular Devices for Hemorrhagic Stroke Industry Trends

8.2 Neurovascular Devices for Hemorrhagic Stroke Market Drivers

8.3 Neurovascular Devices for Hemorrhagic Stroke Market Challenges

8.4 Neurovascular Devices for Hemorrhagic Stroke Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Neurovascular Devices for Hemorrhagic Stroke Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Neurovascular Devices for Hemorrhagic Stroke Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Neurovascular Devices for Hemorrhagic Stroke Market Competitive Situation by Manufacturers in 2024

Table 4. Global Neurovascular Devices for Hemorrhagic Stroke Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Neurovascular Devices for Hemorrhagic Stroke Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Neurovascular Devices for Hemorrhagic Stroke Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Neurovascular Devices for Hemorrhagic Stroke, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Neurovascular Devices for Hemorrhagic Stroke, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Neurovascular Devices for Hemorrhagic Stroke, Product Type & Application

Table 12. Global Key Manufacturers of Neurovascular Devices for Hemorrhagic Stroke, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Neurovascular Devices for Hemorrhagic Stroke by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurovascular Devices for Hemorrhagic Stroke as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Neurovascular Devices for Hemorrhagic Stroke Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Neurovascular Devices for Hemorrhagic Stroke Sales by Region (2020-2025) & (K Units)

Table 18. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Region (2020-2025)

Table 19. Global Neurovascular Devices for Hemorrhagic Stroke Sales by Region (2026-2031) & (K Units)

Table 20. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Region (2026-2031)

Table 21. Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Region (2020-2025)

Table 23. Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Region (2026-2031)

Table 25. North America Neurovascular Devices for Hemorrhagic Stroke Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2020-2025) & (K Units)

Table 27. North America Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2026-2031) & (K Units)

Table 28. North America Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Neurovascular Devices for Hemorrhagic Stroke Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2020-2025) & (K Units)

Table 32. Europe Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2026-2031) & (K Units)

Table 33. Europe Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Neurovascular Devices for Hemorrhagic Stroke Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Neurovascular Devices for Hemorrhagic Stroke Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Neurovascular Devices for Hemorrhagic Stroke Sales (K Units) by Type (2020-2025)

Table 51. Global Neurovascular Devices for Hemorrhagic Stroke Sales (K Units) by Type (2026-2031)

Table 52. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Type (2020-2025)

Table 53. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Type (2026-2031)

Table 54. Global Neurovascular Devices for Hemorrhagic Stroke Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Neurovascular Devices for Hemorrhagic Stroke Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Type (2020-2025)

Table 57. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Type (2026-2031)

Table 58. Global Neurovascular Devices for Hemorrhagic Stroke Price (US$/Unit) by Type (2020-2025)

Table 59. Global Neurovascular Devices for Hemorrhagic Stroke Price (US$/Unit) by Type (2026-2031)

Table 60. Global Neurovascular Devices for Hemorrhagic Stroke Sales (K Units) by Application (2020-2025)

Table 61. Global Neurovascular Devices for Hemorrhagic Stroke Sales (K Units) by Application (2026-2031)

Table 62. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Application (2020-2025)

Table 63. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Application (2026-2031)

Table 64. Global Neurovascular Devices for Hemorrhagic Stroke Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Neurovascular Devices for Hemorrhagic Stroke Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Application (2020-2025)

Table 67. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Application (2026-2031)

Table 68. Global Neurovascular Devices for Hemorrhagic Stroke Price (US$/Unit) by Application (2020-2025)

Table 69. Global Neurovascular Devices for Hemorrhagic Stroke Price (US$/Unit) by Application (2026-2031)

Table 70. Stryker Corporation Company Information

Table 71. Stryker Corporation Description and Business Overview

Table 72. Stryker Corporation Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Stryker Corporation Neurovascular Devices for Hemorrhagic Stroke Product

Table 74. Stryker Corporation Recent Developments/Updates

Table 75. Medtronic Company Information

Table 76. Medtronic Description and Business Overview

Table 77. Medtronic Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Medtronic Neurovascular Devices for Hemorrhagic Stroke Product

Table 79. Medtronic Recent Developments/Updates

Table 80. Johnson & Johnson Company Information

Table 81. Johnson & Johnson Description and Business Overview

Table 82. Johnson & Johnson Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Johnson & Johnson Neurovascular Devices for Hemorrhagic Stroke Product

Table 84. Johnson & Johnson Recent Developments/Updates

Table 85. Terumo Company Information

Table 86. Terumo Description and Business Overview

Table 87. Terumo Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Terumo Neurovascular Devices for Hemorrhagic Stroke Product

Table 89. Terumo Recent Developments/Updates

Table 90. Abbott Vascular Company Information

Table 91. Abbott Vascular Description and Business Overview

Table 92. Abbott Vascular Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Abbott Vascular Neurovascular Devices for Hemorrhagic Stroke Product

Table 94. Abbott Vascular Recent Developments/Updates

Table 95. Acandis Company Information

Table 96. Acandis Description and Business Overview

Table 97. Acandis Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Acandis Neurovascular Devices for Hemorrhagic Stroke Product

Table 99. Acandis Recent Developments/Updates

Table 100. Cerenovus Company Information

Table 101. Cerenovus Description and Business Overview

Table 102. Cerenovus Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Cerenovus Neurovascular Devices for Hemorrhagic Stroke Product

Table 104. Cerenovus Recent Developments/Updates

Table 105. Ceres Endovascular Company Information

Table 106. Ceres Endovascular Description and Business Overview

Table 107. Ceres Endovascular Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Ceres Endovascular Neurovascular Devices for Hemorrhagic Stroke Product

Table 109. Ceres Endovascular Recent Developments/Updates

Table 110. Imperative Care Company Information

Table 111. Imperative Care Description and Business Overview

Table 112. Imperative Care Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Imperative Care Neurovascular Devices for Hemorrhagic Stroke Product

Table 114. Imperative Care Recent Developments/Updates

Table 115. Penumbra Company Information

Table 116. Penumbra Description and Business Overview

Table 117. Penumbra Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Penumbra Neurovascular Devices for Hemorrhagic Stroke Product

Table 119. Penumbra Recent Developments/Updates

Table 120. MicroPort Scientific Company Information

Table 121. MicroPort Scientific Description and Business Overview

Table 122. MicroPort Scientific Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. MicroPort Scientific Neurovascular Devices for Hemorrhagic Stroke Product

Table 124. MicroPort Scientific Recent Developments/Updates

Table 125. NICO Corporation Company Information

Table 126. NICO Corporation Description and Business Overview

Table 127. NICO Corporation Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. NICO Corporation Neurovascular Devices for Hemorrhagic Stroke Product

Table 129. NICO Corporation Recent Developments/Updates

Table 130. Phenox Company Information

Table 131. Phenox Description and Business Overview

Table 132. Phenox Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Phenox Neurovascular Devices for Hemorrhagic Stroke Product

Table 134. Phenox Recent Developments/Updates

Table 135. Rapid Medical Company Information

Table 136. Rapid Medical Description and Business Overview

Table 137. Rapid Medical Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. Rapid Medical Neurovascular Devices for Hemorrhagic Stroke Product

Table 139. Rapid Medical Recent Developments/Updates

Table 140. Shape Memory Medical Company Information

Table 141. Shape Memory Medical Description and Business Overview

Table 142. Shape Memory Medical Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 143. Shape Memory Medical Neurovascular Devices for Hemorrhagic Stroke Product

Table 144. Shape Memory Medical Recent Developments/Updates

Table 145. Wallaby Medical Company Information

Table 146. Wallaby Medical Description and Business Overview

Table 147. Wallaby Medical Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 148. Wallaby Medical Neurovascular Devices for Hemorrhagic Stroke Product

Table 149. Wallaby Medical Recent Developments/Updates

Table 150. Key Raw Materials Lists

Table 151. Raw Materials Key Suppliers Lists

Table 152. Neurovascular Devices for Hemorrhagic Stroke Distributors List

Table 153. Neurovascular Devices for Hemorrhagic Stroke Customers List

Table 154. Neurovascular Devices for Hemorrhagic Stroke Market Trends

Table 155. Neurovascular Devices for Hemorrhagic Stroke Market Drivers

Table 156. Neurovascular Devices for Hemorrhagic Stroke Market Challenges

Table 157. Neurovascular Devices for Hemorrhagic Stroke Market Restraints

Table 158. Research Programs/Design for This Report

Table 159. Key Data Information from Secondary Sources

Table 160. Key Data Information from Primary Sources

Table 161. Authors List of This Report

List of Figures

Figure 1. Product Picture of Neurovascular Devices for Hemorrhagic Stroke

Figure 2. Global Neurovascular Devices for Hemorrhagic Stroke Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Neurovascular Devices for Hemorrhagic Stroke Market Share by Type: 2024 & 2031

Figure 4. Support Devices Product Picture

Figure 5. Neurothrombectomy Devices Product Picture

Figure 6. Global Neurovascular Devices for Hemorrhagic Stroke Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Neurovascular Devices for Hemorrhagic Stroke Market Share by Application: 2024 & 2031

Figure 8. Hospitals

Figure 9. Clinics

Figure 10. Global Neurovascular Devices for Hemorrhagic Stroke Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Neurovascular Devices for Hemorrhagic Stroke Market Size (2020-2031) & (US$ Million)

Figure 12. Global Neurovascular Devices for Hemorrhagic Stroke Sales (2020-2031) & (K Units)

Figure 13. Global Neurovascular Devices for Hemorrhagic Stroke Average Price (US$/Unit) & (2020-2031)

Figure 14. Neurovascular Devices for Hemorrhagic Stroke Report Years Considered

Figure 15. Neurovascular Devices for Hemorrhagic Stroke Sales Share by Manufacturers in 2024

Figure 16. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest Neurovascular Devices for Hemorrhagic Stroke Players: Market Share by Revenue in Neurovascular Devices for Hemorrhagic Stroke in 2024

Figure 18. Neurovascular Devices for Hemorrhagic Stroke Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global Neurovascular Devices for Hemorrhagic Stroke Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Country (2020-2031)

Figure 21. North America Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Country (2020-2031)

Figure 22. United States Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Country (2020-2031)

Figure 25. Europe Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Country (2020-2031)

Figure 26. Germany Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Region (2020-2031)

Figure 33. China Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. China Taiwan Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Indonesia Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Thailand Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Malaysia Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Country (2020-2031)

Figure 43. Latin America Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Neurovascular Devices for Hemorrhagic Stroke by Type (2020-2031)

Figure 53. Global Revenue Market Share of Neurovascular Devices for Hemorrhagic Stroke by Type (2020-2031)

Figure 54. Global Neurovascular Devices for Hemorrhagic Stroke Price (US$/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of Neurovascular Devices for Hemorrhagic Stroke by Application (2020-2031)

Figure 56. Global Revenue Market Share of Neurovascular Devices for Hemorrhagic Stroke by Application (2020-2031)

Figure 57. Global Neurovascular Devices for Hemorrhagic Stroke Price (US$/Unit) by Application (2020-2031)

Figure 58. Neurovascular Devices for Hemorrhagic Stroke Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-2316

Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

Global Bilirubin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-35U2436

Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

Global Intracardiac Echocardiography Catheter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-7J13314

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global End Stage Renal Disease Treatment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-2F6212

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Neurovascular Devices for Hemorrhagic Stroke Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-26B17013

Global Neurovascular Devices for Hemorrhagic Stroke Market Research Report 2025

FEATURED COMPANIES

Neurovascular Devices for Hemorrhagic Stroke Market Size

Neurovascular Devices for Hemorrhagic Stroke Market

Report Scope

Scope of Neurovascular Devices for Hemorrhagic Stroke Market Report

Core Chapters

FAQ for this report

Who are the main players in the Neurovascular Devices for Hemorrhagic Stroke Market report?

What are the Application segmentation covered in the Neurovascular Devices for Hemorrhagic Stroke Market report?

What are the Type segmentation covered in the Neurovascular Devices for Hemorrhagic Stroke Market report?

FEATURED COMPANIES

RELATED REPORTS

$8000

Enterprise User

$8000

Enterprise User

$5800

Enterprise User

$5800

Enterprise User